All News
Filter News
Found 806,258 articles
-
Twist Bioscience and iGEM Partner to Provide Synthetic DNA for iGEM Competition and Registry
4/15/2019
Collaboration to change the way iGEM Competition teams contribute to the Registry of Standard Biological Parts, a free online database for synthetic biologists.
-
Surfacer® Inside-Out® Access Catheter System to be Featured at 2019 Charing Cross (CX) International Annual Symposium
4/15/2019
Positive results of single-center, prospective study to be presented along with several educational sessions
-
Soliton Announces Cellulite Trial Results to be Presented at National Aesthetics Conference on May 11, 2019
4/15/2019
Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that Dr. Elizabeth Tanzi of Capital Laser and Skin Care will present preliminary data from its completed cellulite clinical trial
-
QIAGEN N.V. to Report First Quarter 2019 Results
4/15/2019
QIAGEN N.V. plans as previously announced to release its report on results for the first quarter 2019 on Monday, May 6 at approximately 22:05 Central European Time / 16:05 Eastern Standard Time.
-
The Third Annual WISE Scholarship is Now Accepting Applications from Women in Washington Pursuing a Degree in STEM
4/15/2019
Dr. Alexander Sobel is pleased to continue the WISE Scholarship for another year
-
Aptorum Group Limited Reports 2018 Fiscal Year Financial Results and Business Update
4/15/2019
Today provided a business update and announced financial results for the fiscal year ended December 31, 2018.
-
Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition
4/15/2019
Shanghai Pharmaceuticals Holdings Co. Ltd. (Shanghai Pharma or "the Company") (601607.SH) (2067.HK), a major Chinese pharmaceutical group, has unveiled stock option incentive plans in a milestone move designed to accelerate restructuring and boost global competitiveness.
-
Eagle Pharmaceuticals, Inc. Expands Licensing Agreement for BENDEKA™ with Teva Pharmaceuticals International GmbH
4/15/2019
Eagle Pharmaceuticals, Inc. announced that it has expanded its existing BENDEKA™ licensing agreement with Teva Pharmaceuticals International GmbH.
-
Neptune Expands Existing Offering of Turnkey Solutions in the U.S. to Include Hemp Ingredients
4/15/2019
A U.S.-based supply chain of licenced hemp extract producers has been established, and initial purchase orders are now being processed.
-
Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
4/15/2019
Arrowhead Pharmaceuticals Inc. announced that it has received clearance from the U.S. Food and Drug Administration to proceed with an adaptive Phase 2/3 trial with the potential to serve as a pivotal registrational study of ARO-AAT, the company’s second generation subcutaneously administered RNA interference therapeutic being developed as a treatment for a rare genetic liver disease associated with alpha-1 antitrypsin deficiency.
-
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2019 on May 9
4/15/2019
The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
-
Advancements in Vision Administration, Provider Data Management and Member Self Service Lead SKYGEN USA Enterprise System Enhancements
4/15/2019
In keeping with its dedication to delivering the leading benefits administration platform for vision and dental payers, as well as providing outstanding member and provider experiences, SKYGEN USA today announced new enhancements to its Enterprise System solution.
-
NovaBay Pharmaceuticals Announces New Partner Pharmacy Program
4/15/2019
Affirms long-term commitment to make Avenova convenient for both eye care specialists and patients
-
BiondVax Universal Flu Vaccine Patent Application Accepted in Australia
4/15/2019
The patent application has been filed in eight other jurisdictions, and is under examination in Europe, China, Japan, and the USA.
-
CAR T as Plan B: A Case Study on the Personal and Systemic Difficulties from Immunotherapy and Other Innovative Cancer Treatments
4/15/2019
ER doctor and three-time lymphoma patient discusses experience with an emerging type of treatment, alongside care providers, at the NCCN 2019 Annual Conference
-
Novocure Publishes 2018 Annual Report Featuring Company’s Vision, Mission and Values
4/15/2019
Novocure’s mission and values support its overarching patient-forward vision to make a difference in cancer
-
AdvantEdge Healthcare Solutions Recertifies HIPAA, HITECH, SOC 1 Type 2 And SOC 2 Type 2 Certifications
4/15/2019
AdvantEdge Healthcare Solutions ("AdvantEdge"), a national leading healthcare billing, coding, and practice management company, today announced successful third party recertification for HIPAA and HITECH privacy and security requirements by 360 Advanced as well as SOC 1 Type 2 and SOC 2 Type 2 for information security and transparency
-
Zymeworks Opens Phase 2 Clinical Trial for ZW25 in First-Line HER2-Expressing Metastatic Gastroesophageal Cancers
4/15/2019
Zymeworks Inc. announced it has initiated its global multicenter Phase 2 clinical trial evaluating ZW25 in combination with standard of care chemotherapy for the first-line treatment of HER2-positive metastatic gastric, gastroesophageal junction, and esophageal adenocarcinomas.
-
First Lawsuit in the Nation Filed in the Pre-cut Melon Salmonella Outbreak by Jory Lange and Hans Poppe
4/15/2019
A Kentucky woman filed the first lawsuit in the nation in the Salmonella outbreak linked to pre-cut melons produced by Caito Foods.
-
Global Hirsutism Treatment Market 2019-2023 | Use of Birth Control Pills to Boost Growth | Technavio
4/15/2019
The global hirsutism treatment market is expected to post a CAGR of close to 14% during the period 2019-2023, according to the latest market research report by Technavio.